Scott Gottlieb

Special Partner, Washington DC at New Enterprise Associates

Scott Gottlieb

Scott Gottlieb

Special Partner, Washington DC at New Enterprise Associates

Overview
RelSci Relationships

5593

Number of Boards

19

Birthday

1973

Age

47

Contact Data
Trying to get in touch with Scott Gottlieb? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Relationships
RelSci Relationships are individuals Scott Gottlieb likely has professional access to. A relationship does not necessarily indicate a personal connection.

General Partner, Menlo Park at New Enterprise Associates

Relationship likelihood: Strong

Former President, Chief Executive Officer & Director at Genoptix, Inc.

Relationship likelihood: Strong

Co-Founder at Gradalis, Inc.

Relationship likelihood: Strong

Founder at Tolero Pharmaceuticals, Inc.

Relationship likelihood: Strong

Chairman & President at The Lundberg Institute

Relationship likelihood: Strong

Founding Director-Division of Medical Ethics at NYU Elaine A. & Kenneth G. Langone Medical Center

Relationship likelihood: Strong

Co-Founder at Gradalis, Inc.

Relationship likelihood: Strong

Co-Founder at Strata Oncology, Inc.

Relationship likelihood: Strong

Chairman at Tolero Pharmaceuticals, Inc.

Relationship likelihood: Strong

President & Chief Executive Officer at The Keystone Center

Relationship likelihood: Strong

Paths to Scott Gottlieb
Potential Connections via
Relationship Science
You
Scott Gottlieb
Special Partner, Washington DC at New Enterprise Associates
Education
B.A. in Economics
Class of 1994

Wesleyan University is known for the excellence of its academic and co-curricular programs. About 2,900 undergraduates—and some 200 graduate students—from around the world pursue their classroom studies, research projects, and co-curricular interests in ways that are demanding and intensely rewarding. Here, on a beautiful campus overlooking the Connecticut River, students learn to do productive and innovative work that makes a positive difference in the world—that’s what Wesleyan is about.

MD

The School commits to dramatically advancing the art and science of medical care through an atmosphere of intense collaborative learning, social concern, and scholarly inquiry.

Career History
Special Partner, Washington DC
Current

New Enterprise Associates (NEA) focuses on investments in the technology and healthcare sectors. The firm's investment strategy spans all stages of a company's growth, from seeding innovations in emerging markets to funding early-stage companies in high-growth markets to fueling the growth of market leaders. NEA actively invests in emerging markets, with emphasis on India and China.NEA's investments in the healthcare sector focus on companies that address unmet or underserved clinical needs and that combine improved clinical outcomes with lower costs to the market. The firm targets three areas including biopharmaceuticals, medical devices and healthcare services. The firm has a history of partnering with companies that have pioneered transformative innovations in healthcare, such as balloon angioplasty and laparoscopic surgeryWithin the technology sector, NEA focuses on investments in the electronics, consumer technology, enterprise mobility, virtualization, tech-enabled services, SaaS and cloud computing industries.

Fellow
Current

American Enterprise Institute for Public Policy Research provides industrial design services. AEI produces articles from economics, law, political science, defense and foreign policy studies, ethics, theology, health care, and other fields. The company was founded in 1938 and is headquartered in Washington, DC.

Clinical Assistant Professor
Current

NYU School of Medicine has a proud history that goes back to 1837 and includes initiation of and participation in many of the major events in American medicine through two centuries. In 1837, six years after the granting of the first University charter, the minutes of the meetings of the University Council contained the names of men suggested as professors for the chief branches of medical instruction. In 1841, the University Medical College was organized, and instruction was begun under the following: Surgery, Anatomy; Chemistry; Theory and Practice of Medicine; Institutes of Medicine and Materia Medical; Obstetrics and Diseases of Women and Children. Clinical instruction was started in Bellevue Hospital in 1847, and in 1861 Bellevue Hospital Medical College was founded when a college building was erected on the hospital grounds. With the passing of the years and a deepening conviction that the total medical enterprise should be placed in the scholarly setting of the University, it became clear that University Medical College and Bellevue Hospital Medical College would benefit by consolidating. Thus, the medical school became an integral part of New York University in 1898 under the name of University and Bellevue Hospital Medical College. In 1935 the name was changed to New York University College of Medicine and in 1960 to NYU School of Medicine. The School of Medicine celebrated its sesquicentennial year in 1991.

Boards & Committees
Director
2013 - Prior

Targeted Medical Pharma, Inc. is amedical nutrition company, which engages in the research, development, and commercialization of amino acid based medications. It operates through the following segments: Targeted Medical Pharma (TMP), Complete Claims Processing, Inc. (CCPI), and Amino Nutritionals. The TMP segment offers medical foods and generic pharmaceuticals as PTL. The CCPI segment includes point-of-care dispensing solutions; and billing, and collection services. The Amino Nutritionals segment produces and distributes amino acid based dietary supplements directly to consumers. Its products includes Theramine, AppTrim, and Hypertensa. The company was founded by Elizabeth Charuvastra, William E. Shell, and Kim Giffoni in 1999 and is headquartered in Los Angeles, CA.

Member, Advisory Board
Current

Cancer Commons aims to provide patients and their physicians with the knowledge needed to select the best available therapies and trials, and to continuously update that knowledge based on each patient’s response.

Trustee
Tenure Unconfirmed

Keystone Policy Center inspires leaders to rise above entrenched positions to reach common higher ground.

Non-Profit Donations & Grants

Learn how non-profit organizations benefit from RelSci
$1 - $10K
2011

Keystone Policy Center inspires leaders to rise above entrenched positions to reach common higher ground.

Political Donations
$2,000
2015

Honorary Co-Chairman at Pass USMCA Coalition

$300
2014

The Republican National Committee (RNC) is a U.S. political committee that provides national leadership for the Republican Party of the United States. It is responsible for developing and promoting the Republican political platform, as well as coordinating fundraising and election strategy. It is also responsible for organizing and running the Republican National Convention. Similar committees exist in every U.S. state and most U.S. counties, although in some states party organization is structured by congressional district, allied campaign organizations being governed by a national committee. Reince Priebus is the current RNC Chairman.

$2,400
2013

Senator at Office of the Senator from Louisiana, Bill Cassidy

Public Holdings
Restricted data only for RelSci Professional users.
Events
Speaker
New York City, NY
4th Annual Partnering for Cures

Partnering for Cures is FasterCures' annual meeting that brings together diverse participants to discuss and solve the crucial issues facing the medical research world today. Partnering for Cures is structured with thought-provoking panels that host well-known speakers from the different sectors of the medical world; presenters from organizations that are boasting innovative approaches to the issues facing health; pro-bono, personalized advice from experts across medical research fields; and a unique partnering systems that allows conference participants to schedule meetings throughout the weekend to collaborate and create new approaches to save and improve lives.

Speaker
2018 World Economic Forum Annual Meeting

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Scott Gottlieb. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Scott Gottlieb's profile does not indicate a business or promotional relationship of any kind between RelSci and Scott Gottlieb.